{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T06:45:11Z","timestamp":1785912311529,"version":"3.56.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":24,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI18\/00593"],"award-info":[{"award-number":["PI18\/00593"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.cgh.2026.05.004","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T16:18:27Z","timestamp":1779725907000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The TECCU-Based Telemonitoring Platform for Inflammatory Bowel Disease Is Cost-Effective: A Multicenter GETECCU Trial"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4353-569X","authenticated-orcid":false,"given":"Mariam","family":"Aguas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Del Hoyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Vicente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Barreiro-de Acosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Melcarne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Hernandez-Camba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"Madero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Teresa","family":"Arroyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Sicilia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Chaparro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Dolores","family":"Mart\u00edn-Arranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram\u00f3n","family":"Pajares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Mesonero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Ma\u00f1osa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Chac\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Tosca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Sanroman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Monfort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Empar","family":"Saiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamile","family":"Zabana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Varela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Garc\u00eda-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Faubel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Corsino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sol","family":"Porto-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Brunet-Mas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melodi","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Nos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2026.05.004_bib1","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/ecco-jcc\/jjab029","article-title":"The burden of inflammatory bowel disease in Europe in 2020","volume":"15","author":"Zhao","year":"2021","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.cgh.2026.05.004_bib2","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"STRIDE-II: an update on the Selecting Therapeutic Targets In Inflammatory Bowel Disease (STRIDE) initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD","volume":"160","author":"Turner","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2026.05.004_bib3","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1016\/j.cgh.2022.03.011","article-title":"The impact of the social determinants of health on disparities in inflammatory bowel disease","volume":"20","author":"Anyane-Yeboa","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.05.004_bib4","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.gastha.2023.01.016","article-title":"Multicenter study of nonadherence to self-injectable biologic therapy in patients with inflammatory bowel disease: risk factors and outcomes","volume":"2","author":"George","year":"2023","journal-title":"Gastro Hep Adv"},{"key":"10.1016\/j.cgh.2026.05.004_bib5","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1093\/ibd\/izy102","article-title":"Nonadherence to biologic therapies in inflammatory bowel disease","volume":"24","author":"Wentworth","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2026.05.004_bib6","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/ibd\/izab247","article-title":"Interventions to improve adherence to preventive care in inflammatory bowel disease: a systematic review","volume":"28","author":"Yu","year":"2022","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2026.05.004_bib7","doi-asserted-by":"crossref","first-page":"872","DOI":"10.3111\/13696998.2014.950669","article-title":"Healthcare costs for Crohn\u2019s disease patients treated with infliximab: a propensity weighted comparison of the effects of treatment adherence","volume":"17","author":"Feagan","year":"2014","journal-title":"J Med Econ"},{"key":"10.1016\/j.cgh.2026.05.004_bib8","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cgh.2024.04.042","article-title":"The IBD clinic of tomorrow: holistic, patient-centric, and value-based care","volume":"23","author":"Click","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.05.004_bib9","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3748\/wjg.v29.i7.1139","article-title":"Are we ready for telemonitoring inflammatory bowel disease? a review of advances, enablers, and barriers","volume":"29","author":"Del Hoyo","year":"2023","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2026.05.004_bib10","article-title":"Position statement of the Spanish Working Group on Crohn\u2019s disease and Ulcerative Colitis on the use of Telemedicine in Inflammatory Bowel Disease","volume":"48","author":"Aguas Peris","year":"2025","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.05.004_bib11","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/MEG.0000000000002319","article-title":"French experience with telemedicine in inflammatory bowel disease: a patients and physicians survey","volume":"34","author":"Guillo","year":"2022","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.05.004_bib12","doi-asserted-by":"crossref","DOI":"10.2196\/15505","article-title":"Telemonitoring of Crohn\u2019s disease and Ulcerative Colitis (TECCU): cost-effectiveness analysis","volume":"21","author":"Del Hoyo","year":"2019","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.cgh.2026.05.004_bib13","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.cgh.2020.06.016","article-title":"Cost-effectiveness of telemedicine-directed specialized vs standard care for patients with inflammatory bowel diseases in a randomized trial","volume":"19","author":"Del Hoyo","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.05.004_bib14","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.cgh.2020.04.038","article-title":"Cost-effectiveness of telemedicine-directed specialized vs standard care for patients with inflammatory bowel diseases in a randomized trial","volume":"18","author":"de Jong","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.05.004_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0266464","article-title":"Telemonitoring for patients with inflammatory bowel disease amid the COVID-19 pandemic-a cost-effectiveness analysis","volume":"17","author":"Yao","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.cgh.2026.05.004_bib16","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1136\/gut.2010.220160","article-title":"E-health empowers patients with ulcerative colitis: a randomised controlled trial of the web-guided \u2018Constant-care\u2019 approach","volume":"59","author":"Elkjaer","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2026.05.004_bib17","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1097\/MIB.0000000000000199","article-title":"eHealth: individualization of mesalazine treatment through a self-managed web-based solution in mild-to-moderate ulcerative colitis","volume":"20","author":"Pedersen","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2026.05.004_bib18","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/ibd\/izz252","article-title":"A noninferiority randomized clinical trial of the use of the smartphone-based health applications IBDsmart and IBDoc in the care of inflammatory bowel disease patients","volume":"26","author":"McCombie","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2026.05.004_bib19","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0140-6736(17)31327-2","article-title":"Telemedicine for management of inflammatory bowel disease (myIBDcoach): a pragmatic, multicentre, randomised controlled trial","volume":"390","author":"De Jong","year":"2017","journal-title":"The Lancet"},{"key":"10.1016\/j.cgh.2026.05.004_bib20","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/s41395-018-0272-8","article-title":"A randomized controlled trial of TELEmedicine for patients with inflammatory bowel disease (TELE-IBD)","volume":"114","author":"Cross","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2026.05.004_bib21","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/ibd.21795","article-title":"Randomized, controlled trial of home telemanagement in patients with ulcerative colitis (UC HAT)","volume":"18","author":"Cross","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2026.05.004_bib22","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1080\/00365521.2021.1894602","article-title":"Real-life pilot study on the impact of the telemedicine platform EasyMICI\u2013MaMICI \u00ae on quality of life and quality of care in patients with inflammatory bowel disease","volume":"56","author":"Bonnaud","year":"2021","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2026.05.004_bib23","doi-asserted-by":"crossref","DOI":"10.2196\/11602","article-title":"A web-based telemanagement system for improving disease activity and quality of life in patients with complex inflammatory bowel disease: pilot randomized controlled trial","volume":"20","author":"Del Hoyo","year":"2018","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.cgh.2026.05.004_bib24","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.3390\/healthcare12242538","article-title":"Impact of nursing interventions via telephone and email on the quality of life of patients with inflammatory bowel disease: preliminary results of a comparative observational study","volume":"12","author":"Mercuri","year":"2024","journal-title":"Healthcare"},{"key":"10.1016\/j.cgh.2026.05.004_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0295832","article-title":"Impact of an intervention program on drug adherence in patients with ulcerative colitis: randomized clinical trial","volume":"18","author":"Pacheco","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.cgh.2026.05.004_bib26","doi-asserted-by":"crossref","DOI":"10.2196\/60966","article-title":"Telemonitoring of active inflammatory bowel disease using the app TECCU: short-term results of a multicenter trial of GETECCU","volume":"26","author":"Aguas","year":"2024","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.cgh.2026.05.004_bib27","doi-asserted-by":"crossref","DOI":"10.2196\/jmir.4521","article-title":"How to measure costs and benefits of eHealth interventions: an overview of methods and frameworks","volume":"17","author":"Bergmo","year":"2015","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.cgh.2026.05.004_bib28","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/ecco-jcc\/jjx009","article-title":"Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 2: current management","volume":"11","author":"Harbord","year":"2017","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.cgh.2026.05.004_bib29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/ecco-jcc\/jjw168","article-title":"3rd European evidence-based consensus on the diagnosis and management of Crohn\u2019s disease 2016: part 1: diagnosis and medical management","volume":"11","author":"Gomoll\u00f3n","year":"2017","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.cgh.2026.05.004_bib30","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.3390\/ijerph17061871","article-title":"Adaptation of TECCU app based on patients' perceptions for the telemonitoring of inflammatory bowel disease: a qualitative study using focus groups","volume":"17","author":"Del Hoyo","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.cgh.2026.05.004_bib33","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1017\/S0266462312000062","article-title":"Update of the Dutch manual for costing in economic evaluations","volume":"28","author":"Tan","year":"2012","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.cgh.2026.05.004_bib35","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1524-4733.2007.00245.x","article-title":"Practical guidelines for economic evaluations alongside equivalence trials","volume":"11","author":"Bosmans","year":"2008","journal-title":"Value Health"},{"key":"10.1016\/j.cgh.2026.05.004_bib36","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","article-title":"Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)","volume":"20","author":"Herdman","year":"2011","journal-title":"Qual Life Res"},{"key":"10.1016\/j.cgh.2026.05.004_bib37","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1007\/s11136-018-1877-5","article-title":"Validity of the EQ\u20135D\u20135L and reference norms for the Spanish population","volume":"27","author":"Hernandez","year":"2018","journal-title":"Qual Life Res"},{"key":"10.1016\/j.cgh.2026.05.004_bib38","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/00054725-200407000-00009","article-title":"Shortened questionnaire on quality of life for inflammatory bowel disease","volume":"10","author":"Alcal\u00e1","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2026.05.004_bib39","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s40273-023-01301-7","article-title":"Conducting trial-based economic evaluations using R: a tutorial","volume":"41","author":"Ben","year":"2023","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.cgh.2026.05.004_bib40","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/hec.3633","article-title":"Estimating a cost-effectiveness threshold for the Spanish NHS","volume":"27","author":"Vallejo-Torres","year":"2018","journal-title":"Health Econ"},{"key":"10.1016\/j.cgh.2026.05.004_bib41","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S2468-1253(23)00003-1","article-title":"The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission","volume":"8","author":"Burisch","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.05.004_bib42","article-title":"The costs of home monitoring by telemedicine vs standard care for inflammatory bowel diseases\u2014a Danish register-based, 5-year follow-up study","volume":"19","author":"Al-Sheikh","year":"2024","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.cgh.2026.05.004_bib43","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/apt.70267","article-title":"Meta-analysis: intravenous versus subcutaneous infliximab in inflammatory bowel disease","volume":"62","author":"Chetwood","year":"2025","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2026.05.004_bib44","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/MEG.0000000000002850","article-title":"Systematic review with meta-analysis of the effectiveness of subcutaneous biologics versus intravenous biologics in inflammatory bowel diseases","volume":"37","author":"Elford","year":"2025","journal-title":"Eur J Gastroenterol Hepatol"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356526003514?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356526003514?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T05:52:03Z","timestamp":1785909123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356526003514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":41,"alternative-id":["S1542356526003514"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2026.05.004","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The TECCU-Based Telemonitoring Platform for Inflammatory Bowel Disease Is Cost-Effective: A Multicenter GETECCU Trial","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2026.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Gastroenterological Association Institute.","name":"copyright","label":"Copyright"}]}}